Home / Drug shortages / Ifosfamide Injection

Ifosfamide Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Ifosfamide Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 06/12/2026. Reported reason: Demand increase for the drug

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0143-9530-01
Dosage Form
Injection
Presentation
Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01)
Initial Posting
06/12/2026
Revised Date

Reason

Demand increase for the drug

FDA data resources